MGLAX | MGLKX | MGLAX / MGLKX | |
Total Expense Ratio | 1.19 | 1.44 | 83% |
Annual Report Gross Expense Ratio | 1.20 | 1.45 | 83% |
Fund Existence | 16 years | 11 years | - |
Gain YTD | 3.500 | 3.290 | 106% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 1000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.22B | 2.22B | 100% |
Annual Yield % from dividends | 2.25 | 1.86 | 121% |
Returns for 1 year | 2.15 | 1.89 | 114% |
Returns for 3 years | -4.47 | -4.92 | 91% |
Returns for 5 years | 13.27 | 12.12 | 109% |
Returns for 10 years | 28.83 | 17.16 | 168% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
VYMYX | 20.05 | 0.16 | +0.80% |
Voya Mid Cap Research Enhanced Index W | |||
OTCNX | 78.78 | 0.47 | +0.60% |
Invesco Discovery Large Cap R | |||
GGFRX | 15.02 | 0.07 | +0.47% |
Nationwide BNY Mellon Dyn US Core R | |||
GCVAX | 24.55 | 0.07 | +0.29% |
Goldman Sachs Large Cp Val Insghts A | |||
LHCOX | 18.64 | 0.05 | +0.27% |
Lord Abbett Health Care F3 |